Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Single Blind, Randomized, Placebo Controlled, Parallel Group Study to Investigate the Safety and Tolerability of SF2000SD in Healthy Male Volunteers

NCT02941159 is registered in ClinicalTrials.gov with Tropical Diseases Research Centre, Zambia as lead sponsor.

NCT NCT02941159
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02941159 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Single Blind, Randomized, Placebo Controlled, Parallel Group Study to Investigate the Safety and Tolerability of SF2000SD in Healthy Male Volunteers
Lead sponsor
Tropical Diseases Research Centre, Zambia
Phase
Phase 1
Overall status
Unknown status
Start date
September 30, 2016
Completion date
February 28, 2018
Enrollment
43 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

good health